Jiping Zha
- Molecular Biology top 0.5%
- Oncology top 1%
- Immunology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Stanley J. KorsmeyerJennifer JockelElizabeth YangHisashi HaradaLawrence BoiseCraig B. ThompsonSolly WeilerKyoung Joon Oh
- Topics
- Cell death mechanisms and regulation (11 papers)Cancer Immunotherapy and Biomarkers (8 papers)Cancer-related Molecular Pathways (6 papers)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Jiping Zha
39 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 6.2k
- Oncology 1.9k
- Immunology 1.2k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 823
Countries citing papers authored by Jiping Zha
This map shows the geographic impact of Jiping Zha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiping Zha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiping Zha more than expected).
Fields of papers citing papers by Jiping Zha
This network shows the impact of papers produced by Jiping Zha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiping Zha. The network helps show where Jiping Zha may publish in the future.
Co-authorship network of co-authors of Jiping Zha
This figure shows the co-authorship network connecting the top 25 collaborators of Jiping Zha. A scholar is included among the top collaborators of Jiping Zha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiping Zha. Jiping Zha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 69 | |
| 6 | 150 | |
| 7 | 89 | |
| 8 | 83 | |
| 9 | 54 | |
| 10 | 21 | |
| 11 | 66 | |
| 12 | 82 | |
| 13 | Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors | 9 |
| 14 | IAP (inhibitor of apoptosis) antagonist inhibits orthotopic lung tumor growth | 1 |
| 15 | 372 | |
| 16 | 185 | |
| 17 | Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cellsbreakdown → | 523 |
| 18 | 256 | |
| 19 | Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XLbreakdown → | 2210 |
| 20 | Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathbreakdown → | 1819 |
About Jiping Zha
Jiping Zha is a scholar working on Oncology, Hepatology and Molecular Biology, having authored 43 papers that have together received 8.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Molecular Biology (6.2k citations), Oncology (1.9k citations) and Cancer Research (1.0k citations). Jiping Zha has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Stanley J. Korsmeyer, Jennifer Jockel, Elizabeth Yang, Hisashi Harada, Lawrence Boise, Craig B. Thompson, Solly Weiler, Kyoung Joon Oh, Michael C. Wei and Ingo Schmitz. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.